You are here: Industry Insights > cancer

News List

AstraZeneca and Cancer Research UK open functional genomics centre pharmaceutical
December 13, 2018
AstraZeneca has partnered with Cancer Research UK to open a functional genomics centre of excellence focused on accelerating the discovery and development of new oncology medicines.
Litmus and NIH study use of wearables in cancer R&D pharmaphorum
December 13, 2018
Health data firm Litmus Health has been awarded a contract with the National Cancer Institute of the US National Institutes of Health, to use “real-world” digital data to improve drug development.
Sprayable gel with CD47 blockers could be the future of drug delivery for cancer europeanpharmaceuticalreview
December 13, 2018
A sprayable gel containing calcium carbonate nanoparticles with antibodies targeted to block CD47, could be the future of drug delivery for cancer…
Rural patients less likely to survive cancer, study finds pharmatimes
December 13, 2018
The global review, by researchers at the University of Aberdeen, examined 39 studies from developed countries and found that people living in rural locations were 5% less likely to survive cancer.
Amgen contributes $2 million to groundbreaking program providing cancer patients of all backgrounds access to U.S. clinical trials worldpharmanews
December 12, 2018
Amgen and the Lazarex Cancer Foundation have teamed up to support more equitable access to clinical trials for cancer patients in the U.S.
Bristol-Myers and Vedanta to study combination therapy for cancer pharmaceutical-technology
December 12, 2018
Bristol-Myers Squibb has partnered with PureTech Health subsidiary Vedanta Biosciences to study its Opdivo in combination with VE800 drug candidate for the treatment of advanced or metastatic cancers.
First U.S.-Cuba biotech JV to bring Cuban-developed cancer vaccines to the U.S. fiercepharma
December 11, 2018
Three years after the U.S. and Cuba restored their diplomatic relations, the first biotech joint venture between institutions from the two countries has launched with the mission of bringing some novel...
AstraZeneca’s Imfinzi fails to meet main goals in head and neck cancer study expressbpd
December 11, 2018
The study, known as ‘EAGLE’, did not improve overall survival compared with standard chemotherapy in patients with the hard-to-treat disease
J&J makes Xarelto case for clot prevention in cancer fiercepharma
December 06, 2018
SAN DIEGO—Johnson & Johnson's clot-busting Xarelto may not have hit the primary goal in its latest trial...
UK cancer patients waiting months for accurate diagnosis pharmatimes
December 06, 2018
Cancer patients in the UK have reported that they continue to face difficulties in receiving a timely diagnosis, according to a survey commissioned by the All.Can initiative, presented at the Britain Against Cancer conference in London.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page